SAN DIEGO--(BUSINESS WIRE)--QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs ...

SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, ...

Investing.com – Quidel stock (NASDAQ:QDEL) traded 2% higher in Wednesday’s premarket after the company said its testing kits are able to detect omicron, the coronavirus variant that’s raging across ...

Quidel Corporation QDEL has been gaining on the back of its strong diagnostics portfolio. A solid third-quarter 2021 performance, along with solid potential in In-Vitro Diagnostics (“IVD”) products, ...

WASHINGTON (AP) Â Speed and accuracy are key features when screening for coronavirus. Quidel Corp. is one of a handful of U.S. companies authorized to sell a rapid test for COVID-19, yielding results ...

Quidel's Q4 revenue and earnings dropped sharply from the prior-year period. However, the company's results topped consensus estimates. Quidel's future growth drivers include the U.S. launch of a new ...

SAN DIEGO, May 26, 2022 (GLOBE NEWSWIRE) -- Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic ...

SAN FRANCISCO - The Pac-12 Conference announced today that it has entered into an agreement with diagnostic test leader Quidel Corporation to implement up to daily testing for COVID-19 with ...

Quidel Corp., based in San Diego, announced it closed May 27 on the previously announced acquisition of Raritan-based Ortho Clinical Diagnostics Holdings PLC. The deal — which would create a new ...

Quidel Corporation QDEL recently entered into a definitive agreement to acquire Ortho Clinical Diagnostics Holdings plc OCDX. The transaction, which is subject to approval of both the companies’ ...